Stock Price Quote

ACUTAAS CHEMICALS LTD.

NSE : ACUTAASBSE : 543349ISIN CODE : INE00FF01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE1696.65-13.2 (-0.77 %)
PREV CLOSE ( ) 1709.85
OPEN PRICE ( ) 1715.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4888
TODAY'S LOW / HIGH ( )1689.60 1725.05
52 WK LOW / HIGH ( )919.63 1901.35
NSE1699.60-10.4 (-0.61 %)
PREV CLOSE( ) 1710.00
OPEN PRICE ( ) 1720.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1699.60 (153)
VOLUME 206418
TODAY'S LOW / HIGH( ) 1690.00 1728.70
52 WK LOW / HIGH ( )918.77 1902
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-06 2007
Management Info
Nareshkumar Patel - Chairman Nareshkumar Patel - Managing Director
Registered Office

Address Plot No 440/5 & 6,Road No 82,G I D C Sachin,
Surat,
Gujarat-394230

Phone 7227977744 / 7573015366

Email info@acutaas.com

Website www.acutaas.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

22Dec Intimation Of Grant Of Stock Options
We herewith inform that the Nomination and Remuneration Committee has to..
11Nov Acutaas Chemicals informs about analy
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
24Oct Acutaas Chemicals informs about transc
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
17Oct Acutaas Chemicals informs about outcom
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclo..
11Jul Acutaas Chemicals informs about certif
Acutaas Chemicals has informed that it enclosed the certificate dated Ju..

Financials

in Millions
QTR Sep 25 ANNUAL 25
Net Profit728.911595.47
Gross Profit 972.81 2135.76
Operating Profit 1055.752434.78
Net Sales 3051.939898.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  4158.60 (3.42%)
M.Cap ( in Cr)9577.51
Jenburkt Pharma (BSE)
peergroup  1110.90 (5.75%)
M.Cap ( in Cr)490.27
Wockhardt (BSE)
peergroup  1429.20 (2.37%)
M.Cap ( in Cr)23223.38
Procter&Gamble Healt (BSE)
peergroup  5403.95 (0.55%)
M.Cap ( in Cr)8970.22
CORONA Remedies (BSE)
peergroup  1500.70 (1.79%)
M.Cap ( in Cr)9178.29

Shareholding Pattern

FI/BANKS/INSURANCE 4.84%
PROMOTERS 32.66%
NON-INSTITUTION 27.89%
MUTUAL FUNDS/UTI 15.81%
GOVERNMENT 0.01%
FII 0%

About Acutaas Chemicals Ltd.

Acutaas Chemicals Ltd. was incorporated in the year 2007. Its today's share price is 1696.65. Its current market capitalisation stands at Rs 13890.66 Cr. In the latest quarter, company has reported Gross Sales of Rs. 9898.35 Cr and Total Income of Rs.10081.7 Cr. The company's management includes Anita Bandyopadhyay, Richa Goyal, Hetal Gandhi, Girikrishna Maniar, Ram Mohan Lokhande, Virendra Nath Mishra, Chetankumar Vaghasia, Nareshkumar Patel, Nareshkumar Patel, Ekta K Srivastava.

It is listed on the BSE with a BSE Code of 543349 , NSE with an NSE Symbol of ACUTAAS and ISIN of INE00FF01025. It's Registered office is at Plot No 440/5 & 6,Road No 82,G I D C SachinSurat-394230, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bela Mehta & Associates, Maheshwari & Co, VB Choksi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.